URINE DRUG TESTING for pain management may be a challenging business for clinical labs given that compliance officers in the states and in the federal government have successfully pursued lab compliance abuses in this line of business in recent years. Now comes news that private equity firm Ampersand Capital Partners of Wellesley, Massachusetts, is to …
Ampersand Buys Calloway Labs, Enters Pain Management Market Read More »
To access this post, you must purchase The Dark Report.